Sorry, you need to enable JavaScript to visit this website.
Skip to main content
 

Search

Matthew V. Lorenzi, Ph.D.

Matthew V. Lorenzi

MATTHEW V. LORENZI, PH.D.

VICE PRESIDENT
LUNG CANCER DISEASE AREA STRONGHOLD

Matthew Lorenzi, Ph.D. is Vice President, Lung Cancer Disease Area Stronghold Leader for the Oncology Therapeutic Area at Janssen Research & Development, LLC. In this role, Matthew is responsible for the strategic direction of the lung cancer disease area from early drug discovery efforts through clinical development.

Prior to joining Janssen Research & Development, he was a senior oncology leader at Bristol-Myers Squibb, where he directed research teams focused on small molecule and biologics-based drug discovery. In addition, Matthew led an early clinical development team. Within these roles, he brought strong scientific leadership to successfully deliver multiple agents into and through clinical development.

Matthew also productively instituted several key initiatives including an oncology translational medicine research strategy and numerous academic collaborations supporting the clinical development of multiple assets. He served as a member of the Senior Leadership Team for Research, representing oncology drug discovery.

Matthew received his doctorate from the University of Miami, Florida, in Molecular Pharmacology and conducted his postdoctoral fellowship at the National Institutes of Health, Bethesda, Maryland, where he continued as a Senior Staff Fellow.